EJAL 40®
 
EJAL 40® is an injectable biorevitalisation treatment developed to improve skin quality by restoring hydration and supporting the physiological regeneration of the extracellular matrix (ECM). Formulated with high-concentration, non-cross-linked hyaluronic acid of medium molecular weight, it promotes fibroblast activity, helping to enhance collagen, elastin, and endogenous hyaluronic acid production for healthier, firmer, and more elastic skin.
 
Its unique formulation is designed to revitalise ageing and photo-damaged skin without creating volumising effects, making it an excellent choice for comprehensive skin rejuvenation and preventive anti-ageing protocols.
 
Technology & Composition
Non-cross-linked hyaluronic acid: 40 mg / 2 mL (20 mg/mL).
Medium molecular weight hyaluronic acid (approximately 1200–1800 kDa).
Sterile, biodegradable and isotonic injectable gel.
Developed to promote extracellular matrix (ECM) restructuring and dermal bio-stimulation.
High biocompatibility with homogeneous tissue distribution.
 
Packaging
Contents:
1 pre-filled syringe containing 2 mL.
2 sterile 30G ½" needles.
 
Indications & Treatment Areas
Ejal40® is indicated for patients presenting with early to moderate signs of intrinsic or extrinsic skin ageing and reduced dermal quality.
 
Suitable for the treatment of:
Skin laxity.
Fine lines and superficial wrinkles.
Dehydrated or photo-damaged skin.
Loss of elasticity and firmness.
Dermal regeneration.
Acne and superficial scar management.
Stretch marks.
Skin conditioning before dermal filler or other aesthetic procedures.
 
Recommended treatment areas include:
Face.
Neck.
Décolleté.
Hands.
Arms.
Other areas requiring dermal revitalisation, according to the clinical assessment of the healthcare professional.
 
Clinical Benefits
Provides intensive skin hydration.
Supports physiological collagen and elastin synthesis.
Improves skin elasticity, density, and firmness.
Promotes extracellular matrix regeneration.
Helps restore smoother skin texture and facial contours.
Improves overall skin radiance and quality.
Can be incorporated into comprehensive facial rejuvenation and preventive anti-ageing treatment protocols.
 
Treatment Protocol
Ejal40® must only be administered by qualified healthcare professionals trained in aesthetic medicine.
The product may be injected using standard intradermal techniques or the manufacturer's 4 Bio Revitalisation Points (4 BRP®) protocol, designed to achieve homogeneous product distribution while minimising the number of injection points.
Treatment frequency, injection depth, and maintenance sessions should always be adapted according to the patient's clinical assessment and therapeutic objectives.
 
Duration of Results
Treatment longevity varies depending on individual factors including age, skin condition, metabolism, lifestyle, and the treatment protocol selected by the practitioner.
For optimal and sustained skin rejuvenation, periodic maintenance sessions may be recommended as part of a long-term professional aesthetic treatment programme.
 
Manufacturer & Regulatory Information
Manufacturer: Medixa S.r.l. (Italy)
CE Marked Medical Device
Manufactured in Italy
Produced in accordance with European medical device quality standards
Compliant with the applicable European Medical Device Regulation (MDR)
 
For Professional Use Only:
As a trusted distributor in the field of aesthetic medicine, Aesthisave® emphasizes that all our products are intended exclusively for professional use.
These treatments must only be performed by qualified and appropriately trained healthcare professionals, ensuring the highest standards of patient safety and clinical care.